| Literature DB >> 27247772 |
Maria Del Carmen Wacher-Rodarte1, Tanya Paulina Trejo-Muñúzuri1, Jesús Fernando Montiel-Aguirre2, Maria Elisa Drago-Serrano3, Raúl L Gutiérrez-Lucas3, Jorge Ismael Castañeda-Sánchez3, Teresita Sainz-Espuñes3.
Abstract
Pozol is a handcrafted nonalcoholic Mayan beverage produced by the spontaneous fermentation of maize dough by lactic acid bacteria. Lactic acid bacteria (LAB) are carriers of chromosomal encoded multidrug-resistant efflux pumps genes that can be transferred to pathogens and/or confer resistance to compounds released during the fermentation process causing food spoiling. The aim of this study was to evaluate the antibiotic sensibility and the transcriptional expression of ABC-type efflux pumps in LAB isolated from pozol that contributes to multidrug resistance. Analysis of LAB and Staphylococcus (S.) aureus ATCC 29213 and ATCC 6538 control strains to antibiotic susceptibility, minimal inhibitory concentration (MIC), and minimal bactericidal concentration (MBC) to ethidium bromide were based in "standard methods" whereas the ethidium bromide efflux assay was done by fluorometric assay. Transcriptional expression of efflux pumps was analyzed by RT-PCR. LAB showed antibiotic multiresistance profiles, moreover, Lactococcus (L.) lactis and Lactobacillus (L.) plantarum displayed higher ethidium bromide efflux phenotype than S. aureus control strains. Ethidium bromide resistance and ethidium bromide efflux phenotypes were unrelated with the overexpression of lmrD in L. lactics, or the underexpression of lmrA in L. plantarum and norA in S. aureus. These findings suggest that, moreover, the analyzed efflux pumps genes, other unknown redundant mechanisms may underlie the antibiotic resistance and the ethidium bromide efflux phenotype in L. lactis and L. plantarum. Phenotypic and molecular drug multiresistance assessment in LAB may improve a better selection of the fermentation starter cultures used in pozol, and to control the antibiotic resistance widespread and food spoiling for health safety.Entities:
Keywords: Antibiotic resistance; Mayan‐pozol; efflux pumps; ethidium‐bromide; lactic‐acid‐bacteria
Year: 2015 PMID: 27247772 PMCID: PMC4867762 DOI: 10.1002/fsn3.304
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Primers used in this study
| Gen | Oligonucleotide sequences | Amplicon (bp) | Ref |
|---|---|---|---|
|
| |||
|
| F: ATCCCCAAGGTTCTCAAGGT | 174 | This study |
| R: CACCTTGTTTTGCCCATTCT | |||
|
| F: TTATATCGCCGTTTGGTGGT | 246 | |
| R: TCGCTGACATGTAGCCAAAG | |||
|
| |||
|
| F: GTGGTCAAAACAAGGGGAAA | 217 | This study |
| R: TTGTTCACCCATCCAAGTGA | |||
|
| F: GGCAACTTCACATGCTGCTA | 232 | |
| R: AGAGGTGAAACGAGCAAGGA | |||
|
| |||
|
| F: GCCGGGGTTATTCCTGTTAT | 180 | This study |
| R: GAACGTGAAGAGCACGATCA | |||
|
| F: CTAACGCTTTTCCGCAAGTC | 184 | |
| R: GCTAAAGCATCTTGGCGTTC | |||
Annealing temperatures
| Microorganism | Gen | °C |
|---|---|---|
|
|
| 63.5 |
|
| 63.5 | |
|
|
| 55.0 |
|
| 63.5 | |
|
|
| 60.0 |
|
| 52.0 |
Antibiogram tests of control strains and lactic acid bacteria strains
| Strain | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AM | PE | DC | CX | CFX | CF | CPF | CLM | E | TE | GE | NET | K | N | SXT | VA | C | |
|
| S | S | S | S | S | S | I | R | S | S | R | I | S | R | I | S | S |
|
| S | S | S | S | S | S | I | R | S | S | R | I | S | R | I | S | S |
|
| S | S | S | S | S | S | R | R | S | S | R | I | I | R | I | S | S |
|
| S | S | S | S | S | S | S | S | S | S | R | S | S | R | R | S | S |
|
| S | S | S | S | S | S | S | S | S | S | R | S | S | R | R | S | S |
|
| R | R | S | I | S | R | R | I | S | S | R | R | R | R | R | S | S |
|
| R | S | R | R | R | R | R | I | S | S | R | S | R | R | R | R | S |
|
| S | R | R | R | S | R | R | R | S | I | R | S | R | S | I | R | S |
|
| S | S | R | R | S | R | R | R | S | S | R | S | R | R | I | R | S |
|
| S | S | R | R | I | R | R | R | S | I | R | S | R | S | R | R | S |
|
| S | S | R | R | S | R | R | I | S | S | I | S | S | R | R | I | S |
|
| S | S | R | R | S | S | R | S | S | S | I | S | R | S | R | R | S |
|
| S | S | R | R | S | I | R | I | S | I | R | I | R | R | R | R | S |
(S) Sensible, (R) Resistant, (I) Intermediate resistance.
Assays of MIC and MBC to ethidium bromide
| Strain | MIC (μg/mL) | MBC (μg/mL) |
|---|---|---|
|
| 5 | 40 |
|
| 10 | 20 |
|
| 5 | 20 |
|
| <5 | <5 |
|
| <5 | 10 |
|
| <5 | 10 |
|
| 40 | >80 |
|
| 40 | >80 |
|
| >80 | >80 |
|
| >80 | >80 |
|
| 40 | >80 |
|
| >80 | >80 |
|
| >80 | >80 |
MIC, minimal inhibitory concentration; MBC, minimal bactericidal concentration.
Figure 1Accumulative test of ethidium bromide in bacterial strains with significant differences in fluorescence intensity in regard with the control strains assessed for five minutes each during thirty minutes.
Figure 2Agarose gel analysis of RT‐PCR products: (A) ATCC6538 control strain; (B) ; strain A (C) and strain B (D).
Figure 3mRNA expression ratios of efflux pumps from each bacterial strain relative to sec Y mRNA expression with ATCC 6538 as control strain. Data are depicted as mean values plus standard deviation (SD).